Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam R Metwalli

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Urology|February 29, 2020
Long-term Functional and Oncologic Outcomes of Partial Adrenalectomy for PheochromocytomaPatrick T Gomella, Thomas H Sanford, Peter A Pinto, et al.
The Journal of Urology|June 12, 2024
Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal MassesMaria B Antony, Zach Kozel, Nikhil Gopal, et al.
Urology|November 26, 2020
Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell CarcinomaMartin Lang, Cathy D Vocke, Christopher J Ricketts, et al.
International Urology and Nephrology|November 5, 2016
Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko. Bilateral renal cancers: oncological and functional outcomes. Int Urol Nephrol 2016 (Epub ahead of print)Matthew J Watson, Abhinav Sidana, Eric A Singer, et al.
International Urology and Nephrology|August 13, 2016
Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidneyRyan A Hankins, Annerleim Walton-Diaz, Hong Truong, et al.
International Journal of Oncology|April 16, 2016
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approachQingdi Quentin Li, Jian-Jiang Hao, Zheng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical managementBrian Shuch, Srinivas Vourganti, Christopher J Ricketts, et al.
Journal of Endourology|September 22, 2016
Repeat Robotic Partial Nephrectomy: Characteristics, Complications, and Renal Functional OutcomesMatthew J Watson, Abhinav Sidana, Annerleim Walton Diaz, et al.
BJU International|September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBoris A Hadaschik, Peter C Black, Jason C Sea, et al.
Urologic Oncology|March 24, 2019
A comparison of outcomes for standard and multiplex partial nephrectomy in a solitary kidney: The National Cancer Institute experienceJoseph A Baiocco, Mark W Ball, Asha K Pappajohn, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Urology|February 29, 2020
Long-term Functional and Oncologic Outcomes of Partial Adrenalectomy for PheochromocytomaPatrick T Gomella, Thomas H Sanford, Peter A Pinto, et al.
The Journal of Urology|June 12, 2024
Cumulative Impact of Serial Partial Nephrectomy for the Treatment of Recurrent Renal MassesMaria B Antony, Zach Kozel, Nikhil Gopal, et al.
Urology|November 26, 2020
Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell CarcinomaMartin Lang, Cathy D Vocke, Christopher J Ricketts, et al.
International Urology and Nephrology|November 5, 2016
Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko. Bilateral renal cancers: oncological and functional outcomes. Int Urol Nephrol 2016 (Epub ahead of print)Matthew J Watson, Abhinav Sidana, Eric A Singer, et al.
International Urology and Nephrology|August 13, 2016
Renal functional outcomes after robotic multiplex partial nephrectomy: the National Cancer Institute experience with robotic partial nephrectomy for 3 or more tumors in a single kidneyRyan A Hankins, Annerleim Walton-Diaz, Hong Truong, et al.
International Journal of Oncology|April 16, 2016
Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approachQingdi Quentin Li, Jian-Jiang Hao, Zheng Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical managementBrian Shuch, Srinivas Vourganti, Christopher J Ricketts, et al.
Journal of Endourology|September 22, 2016
Repeat Robotic Partial Nephrectomy: Characteristics, Complications, and Renal Functional OutcomesMatthew J Watson, Abhinav Sidana, Annerleim Walton Diaz, et al.
BJU International|September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBoris A Hadaschik, Peter C Black, Jason C Sea, et al.
Urologic Oncology|March 24, 2019
A comparison of outcomes for standard and multiplex partial nephrectomy in a solitary kidney: The National Cancer Institute experienceJoseph A Baiocco, Mark W Ball, Asha K Pappajohn, et al.
Pageof 7